Major Rating Factors:
Weak overall results on stability tests (2.1 on a scale of 0 to 10) including weak risk diversification and negative cash flow from operations for 2024. The largest net exposure for one risk is excessive at 14.3% of capital. Fair profitability index (4.4) with operating losses during 2020, 2021, 2022, 2023 and the first six months of 2025. Average return on equity over the last five years has been poor at -3.3%. Strong long-term capitalization index (7.7) based on excellent current risk adjusted capital (severe and moderate loss scenarios), despite some fluctuation in capital levels.
Other Rating Factors:
Ample reserve history (9.5) that helps to protect the company against sharp claims increases. Superior liquidity (9.8) with ample operational cash flow and liquid investments.
Stability Factors:
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
R - Concerns about the financial strength of its reinsurers.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
VT
Principal Investments:
Investment grade bonds (47.7%), common stock (25.9%), cash (20.4%), other (6.1%)
Ratios
Premium to Surplus
Reserve to Surplus
1-Year Reserve Development
2-Year Reserve Development
Expense Ratio
Combined Ratio
Cash From Underwriting
Net Premium Growth
Investments in Affiliates
--
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
58 East View Lane
Barre, VT 05641
Barre, VT 05641
Phone Number
(800) 416-1143
NAIC Number
12934
Website
Largest Affiliates
No affiliate information available.